KLK3 and neoplasm: The assessment of this disease typically relies on a combination of methods, including Prostate Specific Antigen (PSA) levels; digital rectal examination; and staging through the Tumor, Lymph Node, and Metastasis (TNM) classification system, alongside the European Association of Urology (EAU) risk group categorization.